Published in Am J Epidemiol on March 07, 2008
Missing pieces in the Parkinson's disease puzzle. Nat Med (2010) 2.90
Genetic determinants of hair color and Parkinson's disease risk. Ann Neurol (2009) 2.78
Use of ibuprofen and risk of Parkinson disease. Neurology (2011) 2.70
Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol (2009) 2.46
Family history of melanoma and Parkinson disease risk. Neurology (2009) 2.25
Uric acid as a CNS antioxidant. J Alzheimers Dis (2010) 1.93
Prospective study of statin use and risk of Parkinson disease. Arch Neurol (2012) 1.76
Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology (2012) 1.72
Midlife milk consumption and substantia nigra neuron density at death. Neurology (2015) 1.51
Metabolomic profiling in LRRK2-related Parkinson's disease. PLoS One (2009) 1.19
Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomark Med (2010) 1.13
Pathophysiological roles for purines: adenosine, caffeine and urate. Prog Brain Res (2010) 1.13
Prospective study of restless legs syndrome and mortality among men. Neurology (2013) 1.11
Targets for neuroprotection in Parkinson's disease. Biochim Biophys Acta (2008) 1.08
Fructose and vitamin C intake do not influence risk for developing hypertension. J Am Soc Nephrol (2009) 1.08
Understanding peroxynitrite biochemistry and its potential for treating human diseases. Arch Biochem Biophys (2009) 1.07
The promise of neuroprotective agents in Parkinson's disease. Front Neurol (2011) 0.96
Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology (2016) 0.96
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect (2008) 0.94
Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics (2014) 0.92
Serum urate and probability of dopaminergic deficit in early "Parkinson's disease". Mov Disord (2011) 0.90
Restless legs syndrome and Parkinson's disease in men. Mov Disord (2010) 0.90
Mendelian randomization of serum urate and parkinson disease progression. Ann Neurol (2014) 0.89
Dietary iron intake and risk of Parkinson's disease. Am J Epidemiol (2008) 0.87
An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis. J Neurol (2010) 0.86
Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol (2013) 0.83
Emerging candidate biomarkers for Parkinson's disease: a review. Aging Dis (2013) 0.82
Acetaldehyde and parkinsonism: role of CYP450 2E1. Front Behav Neurosci (2013) 0.81
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies. BMC Neurol (2015) 0.81
Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan. BMC Neurol (2010) 0.80
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives. Int J Mol Sci (2016) 0.80
Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts. J Am Coll Nutr (2014) 0.79
Alcohol Consumption, Types of Alcohol, and Parkinson's Disease. PLoS One (2013) 0.79
Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis. J Clin Neurol (2015) 0.78
Urate as a Marker of Risk and Progression of Neurodegenerative Disease. Neurotherapeutics (2016) 0.78
Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis. PLoS One (2014) 0.77
The role of milk protein in increasing risk of Parkinson's disease. Eur J Epidemiol (2013) 0.76
Intake of antioxidant vitamins and risk of Parkinson's disease. Mov Disord (2016) 0.75
Purines: forgotten mediators in traumatic brain injury. J Neurochem (2016) 0.75
Micronutrients and Risk of Parkinson's Disease: A Systematic Review. Gerontol Geriatr Med (2016) 0.75
Association of Serum Uric Acid Level with the Severity of Brain Injury and Patient's Outcome in Severe Traumatic Brain Injury. J Clin Diagn Res (2016) 0.75
A predictive model to identify Parkinson disease from administrative claims data. Neurology (2017) 0.75
Potential mechanisms for low uric acid in Parkinson disease. J Neural Transm (Vienna) (2016) 0.75
Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener (2017) 0.75
Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol (2017) 0.75
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A (1981) 8.45
Brain dopamine and obesity. Lancet (2001) 8.00
Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med (2004) 6.53
Oxidative stress in Parkinson's disease. Ann Neurol (2003) 5.93
Alcohol intake and risk of incident gout in men: a prospective study. Lancet (2004) 4.12
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology (2001) 3.25
Gout and risk of Parkinson disease: a prospective study. Neurology (2007) 3.09
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol (2001) 3.09
Parkinson's disease. Lancet (2004) 3.08
Plasma urate and risk of Parkinson's disease. Am J Epidemiol (2007) 3.06
The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol (1995) 3.00
Intermediary metabolism of fructose. Am J Clin Nutr (1993) 2.92
Pesticide exposure and risk for Parkinson's disease. Ann Neurol (2006) 2.89
Serum uric acid levels and the risk of Parkinson disease. Ann Neurol (2005) 2.47
Body mass index and the risk of Parkinson disease. Neurology (2006) 2.28
Research diagnostic criteria for Parkinson's disease. Adv Neurol (1990) 2.28
Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2005) 2.25
Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol (1996) 2.08
Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension (2007) 2.05
Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem (2002) 1.99
Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med (2006) 1.85
Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol (2006) 1.76
Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J (2000) 1.75
Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol (1994) 1.70
Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol (2004) 1.54
Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res (1998) 1.50
Diet and Parkinson's disease: a potential role of dairy products in men. Ann Neurol (2002) 1.46
The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum (2005) 1.29
Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum (2007) 1.24
Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology (2005) 1.17
The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease. J Neural Transm Park Dis Dement Sect (1993) 1.14
Effect of ethanol on metabolism of purine bases (hypoxanthine, xanthine, and uric acid). Clin Chim Acta (2005) 1.11
Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol (2003) 1.05
Dopamine-induced apoptosis is mediated by oxidative stress and Is enhanced by cyanide in differentiated PC12 cells. J Neurochem (2000) 1.04
Recent developments in diet and gout. Curr Opin Rheumatol (2006) 1.02
Milk- and soy-protein ingestion: acute effect on serum uric acid concentration. Am J Clin Nutr (1991) 0.99
Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. J Neurosci Res (2005) 0.97
Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet. J Rheumatol (2005) 0.90
The cytotoxic activity of lactoperoxidase: enhancement and inhibition by neuroactive compounds. Free Radic Biol Med (2004) 0.81
Folic acid and xanthine oxidase. Ann Intern Med (1977) 0.78
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA (2006) 7.09
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med (2004) 6.53
Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum (2011) 6.36
Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA (2003) 5.33
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation (2005) 5.29
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum (2008) 4.20
Alcohol intake and risk of incident gout in men: a prospective study. Lancet (2004) 4.12
Genome-wide association study of circulating vitamin D levels. Hum Mol Genet (2010) 4.07
Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr (2009) 4.04
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ (2008) 3.71
Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med (2010) 3.66
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol (2005) 3.58
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum (2002) 3.55
Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum (2012) 3.51
Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol (2002) 3.48
Independent impact of gout on mortality and risk for coronary heart disease. Circulation (2007) 3.39
Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum (2006) 3.26
Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr (2010) 3.19
Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum (2003) 3.13
Coffee, caffeine, and risk of depression among women. Arch Intern Med (2011) 3.05
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A (2007) 3.03
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol (2009) 2.95
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2010) 2.94
Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2008) 2.91
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol (2003) 2.90
Pesticide exposure and risk for Parkinson's disease. Ann Neurol (2006) 2.89
Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med (2007) 2.89
Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol (2010) 2.86
Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med (2005) 2.80
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol (2008) 2.79
Genetic determinants of hair color and Parkinson's disease risk. Ann Neurol (2009) 2.78
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study. Ann Intern Med (2014) 2.76
Use of ibuprofen and risk of Parkinson disease. Neurology (2011) 2.70
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Retracted Multiple sclerosis and Epstein-Barr virus. JAMA (2003) 2.68
Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke (2005) 2.63
The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60
Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60
Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation (2007) 2.58
Smoking is a risk factor for multiple sclerosis. Neurology (2003) 2.55
Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol (2007) 2.53
Physical activity and risk of coronary heart disease in India. Int J Epidemiol (2004) 2.48
Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology (2013) 2.47
Depression and incident stroke in women. Stroke (2011) 2.47
Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol (2009) 2.46
Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int (2005) 2.43
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci (2005) 2.34
Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34
Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol (2006) 2.33
Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med (2007) 2.30
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet (2011) 2.28
The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis (2002) 2.26
Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2005) 2.25
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24
Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov (2006) 2.23
Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA (2005) 2.23
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest (2003) 2.22
Methodologic challenges in studying risk factors for progression of knee osteoarthritis. Arthritis Care Res (Hoboken) (2010) 2.20
Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke (2003) 2.19
A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care (2006) 2.18
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Mov Disord (2012) 2.18
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16
Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2011) 2.14
Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med (2002) 2.13
Association of age, race, and obstetric history with urinary symptoms among women in the Nurses' Health Study. Am J Obstet Gynecol (2003) 2.13
Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med (2012) 2.12
Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation (2005) 2.12
Fish consumption and risk of stroke in men. JAMA (2002) 2.08
Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum (2009) 2.07
Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ (2014) 2.06
Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension (2007) 2.05
Vitamin C intake and serum uric acid concentration in men. J Rheumatol (2008) 2.05